Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity.
N-acetylglucosamine (GlcNAc) branching of Asn (N)-linked glycans inhibits pro-inflammatory T cell responses and models of autoimmune diseases such as Multiple Sclerosis (MS). Metabolism controls N-glycan branching in T cells by regulating de novo hexosamine pathway biosynthesis of UDP-GlcNAc, the do...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60517fbf723743b2b183094b3a13e13c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:60517fbf723743b2b183094b3a13e13c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:60517fbf723743b2b183094b3a13e13c2021-12-02T20:15:52ZIncreasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity.1932-620310.1371/journal.pone.0214253https://doaj.org/article/60517fbf723743b2b183094b3a13e13c2019-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0214253https://doaj.org/toc/1932-6203N-acetylglucosamine (GlcNAc) branching of Asn (N)-linked glycans inhibits pro-inflammatory T cell responses and models of autoimmune diseases such as Multiple Sclerosis (MS). Metabolism controls N-glycan branching in T cells by regulating de novo hexosamine pathway biosynthesis of UDP-GlcNAc, the donor substrate for the Golgi branching enzymes. Activated T cells switch metabolism from oxidative phosphorylation to aerobic glycolysis and glutaminolysis. This reduces flux of glucose and glutamine into the hexosamine pathway, thereby inhibiting de novo UDP-GlcNAc synthesis and N-glycan branching. Salvage of GlcNAc into the hexosamine pathway overcomes this metabolic suppression to restore UDP-GlcNAc synthesis and N-glycan branching, thereby promoting anti-inflammatory T regulatory (Treg) over pro-inflammatory T helper (TH) 17 and TH1 differentiation to suppress autoimmunity. However, GlcNAc activity is limited by the lack of a cell surface transporter and requires high doses to enter cells via macropinocytosis. Here we report that GlcNAc-6-acetate is a superior pro-drug form of GlcNAc. Acetylation of amino-sugars improves cell membrane permeability, with subsequent de-acetylation by cytoplasmic esterases allowing salvage into the hexosamine pathway. Per- and bi-acetylation of GlcNAc led to toxicity in T cells, whereas mono-acetylation at only the 6 > 3 position raised N-glycan branching greater than GlcNAc without inducing significant toxicity. GlcNAc-6-acetate inhibited T cell activation/proliferation, TH1/TH17 responses and disease progression in Experimental Autoimmune Encephalomyelitis (EAE), a mouse model of MS. Thus, GlcNAc-6-Acetate may provide an improved therapeutic approach to raise N-glycan branching, inhibit pro-inflammatory T cell responses and treat autoimmune diseases such as MS.Sung-Uk LeeCarey F LiChristie-Lynn MortalesJudy PawlingJames W DennisAni GrigorianMichael DemetriouMichael DemetriouPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 14, Iss 3, p e0214253 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sung-Uk Lee Carey F Li Christie-Lynn Mortales Judy Pawling James W Dennis Ani Grigorian Michael Demetriou Michael Demetriou Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity. |
description |
N-acetylglucosamine (GlcNAc) branching of Asn (N)-linked glycans inhibits pro-inflammatory T cell responses and models of autoimmune diseases such as Multiple Sclerosis (MS). Metabolism controls N-glycan branching in T cells by regulating de novo hexosamine pathway biosynthesis of UDP-GlcNAc, the donor substrate for the Golgi branching enzymes. Activated T cells switch metabolism from oxidative phosphorylation to aerobic glycolysis and glutaminolysis. This reduces flux of glucose and glutamine into the hexosamine pathway, thereby inhibiting de novo UDP-GlcNAc synthesis and N-glycan branching. Salvage of GlcNAc into the hexosamine pathway overcomes this metabolic suppression to restore UDP-GlcNAc synthesis and N-glycan branching, thereby promoting anti-inflammatory T regulatory (Treg) over pro-inflammatory T helper (TH) 17 and TH1 differentiation to suppress autoimmunity. However, GlcNAc activity is limited by the lack of a cell surface transporter and requires high doses to enter cells via macropinocytosis. Here we report that GlcNAc-6-acetate is a superior pro-drug form of GlcNAc. Acetylation of amino-sugars improves cell membrane permeability, with subsequent de-acetylation by cytoplasmic esterases allowing salvage into the hexosamine pathway. Per- and bi-acetylation of GlcNAc led to toxicity in T cells, whereas mono-acetylation at only the 6 > 3 position raised N-glycan branching greater than GlcNAc without inducing significant toxicity. GlcNAc-6-acetate inhibited T cell activation/proliferation, TH1/TH17 responses and disease progression in Experimental Autoimmune Encephalomyelitis (EAE), a mouse model of MS. Thus, GlcNAc-6-Acetate may provide an improved therapeutic approach to raise N-glycan branching, inhibit pro-inflammatory T cell responses and treat autoimmune diseases such as MS. |
format |
article |
author |
Sung-Uk Lee Carey F Li Christie-Lynn Mortales Judy Pawling James W Dennis Ani Grigorian Michael Demetriou Michael Demetriou |
author_facet |
Sung-Uk Lee Carey F Li Christie-Lynn Mortales Judy Pawling James W Dennis Ani Grigorian Michael Demetriou Michael Demetriou |
author_sort |
Sung-Uk Lee |
title |
Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity. |
title_short |
Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity. |
title_full |
Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity. |
title_fullStr |
Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity. |
title_full_unstemmed |
Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity. |
title_sort |
increasing cell permeability of n-acetylglucosamine via 6-acetylation enhances capacity to suppress t-helper 1 (th1)/th17 responses and autoimmunity. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2019 |
url |
https://doaj.org/article/60517fbf723743b2b183094b3a13e13c |
work_keys_str_mv |
AT sunguklee increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity AT careyfli increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity AT christielynnmortales increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity AT judypawling increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity AT jameswdennis increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity AT anigrigorian increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity AT michaeldemetriou increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity AT michaeldemetriou increasingcellpermeabilityofnacetylglucosaminevia6acetylationenhancescapacitytosuppressthelper1th1th17responsesandautoimmunity |
_version_ |
1718374527986040832 |